Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
08/2010
08/05/2010WO2010042867A3 Activators of human pyruvate kinase
08/05/2010WO2010031708A3 Ortho-aminoanilides for the treatment of cancer
08/05/2010US20100197928 Method for preparing disubstituted piperidine and intermediates
08/05/2010US20100197736 Cetp activity inhibitors
08/05/2010US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
08/05/2010US20100197734 Pleuromutilin derivatives and their use as antimicrobials
08/05/2010US20100197732 Repaglinide Substantially Free of Dimer Impurity
08/05/2010US20100197715 Piperidine derivatives
08/05/2010US20100197691 Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197680 Lactam-substituted dicarboxylic acids and use thereof
08/05/2010US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists
08/05/2010US20100197665 Indazole derivatives as kinase inhibitors for the treatment of cancer
08/05/2010US20100197640 Novel sulfamoyl-phenyl-ureido compounds and their use as medicament
08/05/2010CA2750967A1 Sulfamoyl-phenyl-ureido benzamidine-derivatives as antimalarial agents
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010CA2746967A1 Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
08/04/2010EP2212288A1 Crystalline form of piperidine compound
08/04/2010EP2212287A1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
08/04/2010EP2029540B1 Benzamide derivatives and uses related thereto
08/04/2010CN1950362B Process for the preparation of tryptase inhibitors
08/04/2010CN101796027A N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/04/2010CN101792412A Method for synthesizing 1,2,3,4-tetrahydropyridine derivatives from chain 1,3-dicarbonyl compound in one-pot method
08/03/2010US7767814 2-benzyl-3-[4a-(3-hydroxy-phenyl)-10a-methyl-3,4,4a,5,10,10a-hexahydro-1H-benzo[g]isoquinolin-2-yl]-propionic acid, used for prevention or treatment of gastrointestinal disorders, obesity, pain and reducing side effects associated with an opioid such as constipation, nausea and vomiting
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767695 Substituted piperidines
08/03/2010US7767693 inhibition of heat shock protein 90 (HSP90) comprising administering benzoyl compounds or prodrugs,as antitumor agents
08/03/2010US7767692 1-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compounds
08/03/2010US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
08/03/2010US7767671 3-Quinolinecarbonitrile protein kinase inhibitors
08/03/2010US7767666 Butyl and butynyl benzyl amine compounds
08/03/2010US7767663 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
08/03/2010US7767662 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents
08/03/2010US7767626 3-arylphenyl sulfide derivative and insecticide and miticide
08/03/2010US7767623 agricultural fungicides; silane or silanol substituted hetero(thio)carbonylaminobenzene compounds; corresponding anilino intermediates
08/03/2010US7767073 electrooxidation reaction using 2-(N-pyrrolidine)-N,N,N-triethylethanammonium tetrafluoroborate or 3-N-piperidine-N,N,N-triethylammoniopropanesulphonamide tetrafluoroborate; proline final product
08/03/2010CA2459311C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
07/2010
07/29/2010WO2010084516A1 Process for producing optically active n-alkyl-piperidine-2-carboxanilide
07/29/2010WO2010083570A1 Novel metabolic disease therapy
07/29/2010WO2010049946A3 Thyroid receptor ligands
07/29/2010US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity
07/29/2010US20100190898 Weakly Basic Hindered Amines Compounds Having Carbonate Skeletons, Synthetic Resin Compositions And Coating Compositions
07/29/2010US20100190829 Renin inhibitors
07/29/2010US20100190824 Novel Substituted Piperidones as HSP Inducers
07/29/2010US20100190789 Piperidine/piperazine derivatives
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190688 Tetrapeptide analogs
07/29/2010US20100189708 Hydroxy piperidine derivatives to treat gaucher disease
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/28/2010EP2209764A1 Gsm intermediates
07/28/2010EP2076494B1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds
07/28/2010EP1954677B1 Thiomorpholine compound and process for preparing the same
07/28/2010CN101790516A Novel substituted piperidones as hsp inducers
07/28/2010CN101786991A Substituted tetracycline compounds
07/27/2010US7763732 Indole derivatives
07/27/2010US7763657 such as N-{-4-[3-(4-t-butylbenzyl)ureidomethyl]-2-vinylphenyl}methanesulfonamide, used as analgesics, and for treating psoriasis, pruritus, asthma, chronic obstructive pulmonary disease, urinary incontinence, inflammatory bowel disease, tinnitus and ischemia
07/27/2010US7763639 1-ethyl-4-[2-fluoro-3-(methylsulfonyl)phenyl]piperidine, havinf therapeutic effects against disorders in the central nervous system, such as dyskinesia
07/22/2010WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010083264A1 Novel benzenesulfonamides as calcium channel blockers
07/22/2010WO2010081851A1 Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
07/22/2010US20100184805 Renin inhibitors
07/22/2010CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010CA2747752A1 Novel benzenesulfonamides as calcium channel blockers
07/21/2010EP2208726A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
07/21/2010EP2114383B1 Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
07/21/2010EP1893573B1 Inhibitors of hcv replication
07/21/2010EP1613621B1 Prostaglandin analogs as ep4 receptor agonists
07/21/2010CN1930125B Biphenyl compounds useful as muscarinic receptor antagonists
07/21/2010CN101784524A Ionic liquids
07/21/2010CN101781274A Acylated piperazine dipeptidyl peptidase IV inhibitor
07/21/2010CN101781243A Pharmaceutical intermediate, preparation method thereof and method for preparing iloperidone by pharmaceutical intermediate
07/21/2010CN101780080A Selective serotonin 2a/2c receptor inverse agonists as therapeutics for neurodegenerative diseases
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759364 Method for producing non-hydrated fexofenadine hydrochloride and a novel crystalline form obtained thereby
07/20/2010CA2581582C Cyclopropyl piperidine glycine transporter inhibitors
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2407866C Process for the synthesis of amine ethers from secondary amino oxides
07/15/2010WO2010081070A2 Novel forms of eperisone
07/15/2010WO2010080787A1 Synthesis of methylphenidate and analogs thereof
07/15/2010WO2010080398A1 Sulfonamides as trpm8 modulators
07/15/2010WO2010079102A1 Polymerisation initiator
07/15/2010WO2010027113A3 Process for preparing (s)-(-)-felodipine
07/15/2010US20100179327 Synthesis of Methylphenidate and Analogs Thereof
07/15/2010US20100179190 Bicyclic pyrazolo protein kinase modulators
07/15/2010US20100179119 Inhibitors of Integrin Alpha2Beta1 Based on Prolyl Diaminopropionic Acid Scaffold
07/15/2010US20100179114 S-Isomer of 2- piperidine and Other Dermal Anesthetic Agents
07/15/2010US20100179109 Renin inhibitors
07/15/2010CA2748912A1 Polymerisation initiator
07/15/2010CA2747662A1 Sulfonamides as trpm8 modulators
07/14/2010EP2206712A1 "Alkaloid aminoester derivatives and medicinal composition thereof"
07/14/2010EP2205583A2 N-heterocyclic biaryl carboxamides as ccr receptor antagonists
07/14/2010EP2205561A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor
07/14/2010EP2205559A1 Renin inhibitors
07/14/2010EP1699778B1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics
07/14/2010EP1071807B1 Method for enzymatic enantiomer-separation of 3(r)- and 3(s)-hydroxy-1- methyl-4-(2,4, 6-trimethoxyphenyl)-1, 2,3,6- tetrahydro-pyridine or its carboxylic acid esters
07/14/2010CN101778852A bisamide-zinc bases
07/14/2010CN101778821A Synthesis of n-(4-fluorobenzyl)-n-(l-methylpiperidin-4-yl)-n'-(4- (2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
07/14/2010CN101778820A Benzoyl-piperidine derivatives as dual modulators of the 5-ht2a and d3 receptors
07/14/2010CN101775013A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
07/14/2010CN101774965A Method for extracting betaxanthin from cockscomb
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 380